Navigation Links
Genomics Firm Nabsys Completes Financial Restructuring and Reinstates Technical Leadership Team
Date:3/31/2016

PROVIDENCE, R.I., March 31, 2016 /PRNewswire/ -- Genomics firm Nabsys has completed a financial  restructuring under the leadership of founding CEO, Barrett Bready, M.D., who returned to the company in October 2015. In addition, members of the original technical leadership team, including Chief Technology Officer, John Oliver, Ph.D., Executive Vice President of Product Development, Steve Nurnberg and Vice President of Software and Informatics, Michael Kaiser have returned to the company.

Dr. Bready served as CEO of Nabsys from 2005-2014 and raised $50 million to develop the company's high definition electronic DNA mapping platform. In early 2015, under different leadership, the company pivoted to a different and ultimately unsuccessful technical approach. Dr. Bready returned to Nabsys in October 2015, recruited back the technical leadership team and has re-focused the company on its core technology.

Nabsys has developed semiconductor-based nanodetectors to analyze very long DNA molecules electronically, at high velocity and with much greater resolution than offered by optical approaches. This technology allows researchers, and will ultimately allow clinicians, to draw conclusions about DNA that would be difficult or impossible with other technologies. 

"I'm grateful that all members of our technical leadership team have returned to Nabsys in recent months," said Bready. "The fact that we were able to get the team organized so quickly meant that very little time was lost during this transition period. The past six months have been the most productive in the company's history."

John Oliver, Ph.D., added, "The Nabsys platform is incredibly powerful when applied to the right challenges and has an unprecedented ability to scale. We are excited to once again be exploring the potential of this technology as a team and anticipate sharing our progress in the near future."

About Nabsys
Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to receive a "1000 Genome" award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genomics-firm-nabsys-completes-financial-restructuring-and-reinstates-technical-leadership-team-300243783.html


'/>"/>
SOURCE Nabsys
Copyright©2016 PR Newswire.
All rights reserved


Related biology news :

1. Newborn Screening Ontario Inks Deal with Tute Genomics, UNIConnect Team to Deliver Informatics Infrastructure for NGS Testing
2. Rubicon Genomics Announces Eurofins Scientific Will Distribute Its Suite of DNA Library Preparation Kits in U.S.
3. Den 10. internationale konference om Genomics (ICG-10) åbner i oktober
4. La 10e International Conference on Genomics (ICG-10) doit souvrir en octobre
5. La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre
6. The 10th International Conference on Genomics (ICG-10) to Open in October
7. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
8. ACT Genomics Raises $8 Million in its First Private Funding Round
9. Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine
10. The Genome Institute at Washington University Receives Irys System from BioNano Genomics to Advance Research for Genome Reference Consortium
11. Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/4/2019)... ... ... Harper was three years old when her owners took her to the ... osteoarthritis in the joints. She was referred to a veterinary specialist to perform ... Dr. Christopher Eich of Southern California Veterinary Specialty Hospital , examined Harper and ...
(Date:6/4/2019)... , ... June 04, 2019 , ... Lajollacooks4u is delighted ... recipients. The recognition, which honors hospitality excellence, is given only to businesses that have ... Excellence for five consecutive years. , To qualify for the Certificate of ...
(Date:6/1/2019)... ... May 31, 2019 , ... The University of ... invested in BioFactura’s $6M Series B Financing Round. , “With the commitment ... who bring significant financial and business resources to bear as we advance our ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... ... the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy ... Novartis company, will have dedicated manufacturing space at the new, state-of-the-art commercial ...
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the BIO ... National Corn Growers Association (NCGA) announced the winners of the Consider Corn Challenge ... or process using field corn to produce biobased materials. , “Corn is a ...
(Date:6/26/2019)... ... ... Alice Branton today released research results from preclinical trials on the beneficial impact ... to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... Over 142% increase in particle size , Over 3% alteration ...
(Date:6/12/2019)... ... June 12, 2019 , ... Leak Detection Associates (LDA), ... Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is excited to announce that ... grant exclusive rights for Zillion to represent LDA in all of China. ...
Breaking Biology Technology: